Author: postfinde

Curida, Small Molecules and Biologics CDMO, Secures Equity Investment and Appoints new CEO

OSLO, NORWAY – Curida Holding AS (“Curida”) has announced a significant growth investment from Signet Healthcare Partners (“Signet”), a New York-based healthcare private equity firm together with existing shareholders, Canica, Investinor, Klaveness Marine and Farvatn Private Equity. This investment will enable Curida to accelerate its expansion plans, including enhancing facility capabilities and growing its industry […]

Curida leverer positivt halvårsresultat etter å ha femdoblet underskuddet i fjor

Eiendomssalg til Elverum kommune og salgsvekst er blant flere grunner til at Curida går i pluss etter et underskudd på 50 millioner kroner i 2022.  Salget til Curida økte med 38 prosent i 2022, og har fortsatt å øke med like stor prosentandel i årets første halvår. – Veksten er drevet av kunder og prosjekter […]

Curida acquires biologics manufacturer Diatec

Curida continues to grow in the international pharma outsourcing market. Through the acquisition of Norwegian company Diatec, Curida takes the first steps into biological production. Curida has a clear growth strategy and broadens its capabilities through the acquisition of Oslo based Diatec. This strengthens the base on which Curida aims to grow further in the […]